Y-MABS THERAPEUTICS
YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients through immunotherapies. YmAbs utilizes its platform technologies to create next-generation humanized, affinity matured bispecific antibodies. To further improve its bispecific antibodies, the company collaborates on the development of a novel human protein tag that dimerizes T-cell engaging bispecific antibodies, which enables higher tumor binding and results in a longer ser... um half-life and a significantly greater T-cell mediated killing of tumor cells. YmAbs' treatments claims to potentially reduce longer-term toxicities associated with current chemotherapeutics and provide the potential for curative therapy even for patients with widespread disease. YmAbs’ goal is to drive multiple product candidates in select solid tumor cancers to FDA approval.
Y-MABS THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2015-04-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ymabs.com
Total Employee:
51+
Status:
Active
Contact:
1 212 847 9841
Email Addresses:
[email protected]
Total Funding:
338.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Sofinnova Investments
Sofinnova Investments investment in Private Equity Round - Y-mAbs Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Private Equity Round - Y-mAbs Therapeutics
Scopia Capital
Scopia Capital investment in Private Equity Round - Y-mAbs Therapeutics
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Private Equity Round - Y-mAbs Therapeutics
Official Site Inspections
http://www.ymabs.com Semrush global rank: 3.96 M Semrush visits lastest month: 3.14 K
- Host name: 172.67.138.62
- IP address: 172.67.138.62
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
